Side by side
Cagrilintide vs Mazdutide
Both are discussed for weight loss. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.
| Cagrilintide | Mazdutide | |
|---|---|---|
| What it is | A long-acting amylin analogue in late-stage trials. It works on a different satiety pathway from the GLP-1 drugs. Which is why it is being developed alongside semaglutide rather than against it. | A GLP-1 and glucagon dual agonist approved in China in 2026. Not approved in the United States, and the US pathway is undecided. |
| EvidenceHow much human evidence exists, not how well it works. | Clinical trials | Approved for another indication |
| Regulatory statusReviewed 2026-08-16 | Not approved anywhere, alone or in combination. In late-stage clinical development as CagriSema, a fixed combination with semaglutide. Anything sold as cagrilintide today is a research chemical produced outside the manufacturing controls that a future approval would rest on. | Approved in China in 2026 for weight management. Not approved by the FDA or the EMA, and a United States filing depends on a partnership decision rather than on further data. Material sold as a research chemical is not the approved Chinese product. |
| Routes | Subcutaneous | Subcutaneous |
| Half-life | 180 hours | 160 hours |
| Cheapest per mgVials only, read from vendors' own listings and dated on the price index. | $4.40/mg | $5.25/mg |
| Median per mg | $9.60/mg | $9.95/mg |
| Vendors with a price | 31 | 8 |
| Storage once mixed | Refrigerated at 2–8 °C. Do not freeze once mixed. | Refrigerated at 2–8 °C. Do not freeze once mixed. |
Compare two other compounds · The full price index
This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.